DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Sikov WM, Polley MY, Twohy E, Perou CM, Singh B, Berry DA. et al.
CALGB (Alliance) 40603: Long-term outcomes (LTOs) after neoadjuvant chemotherapy (NACT) +/- carboplatin (Cb) and bevacizumab (Bev) in triple-negative breast cancer (TNBC).
J Clin Oncol 2019;
37: 591
Access:
We do not assume any responsibility for the contents of the web pages of other providers.